These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30143685)

  • 21. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?
    Jobin ML; Alves ID
    Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).
    Takayama K; Nakase I; Michiue H; Takeuchi T; Tomizawa K; Matsui H; Futaki S
    J Control Release; 2009 Sep; 138(2):128-33. PubMed ID: 19465072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine-rich peptides: methods of translocation through biological membranes.
    Futaki S; Hirose H; Nakase I
    Curr Pharm Des; 2013; 19(16):2863-8. PubMed ID: 23140459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ionpair-π interactions favor cell penetration of arginine/tryptophan-rich cell-penetrating peptides.
    Walrant A; Bauzá A; Girardet C; Alves ID; Lecomte S; Illien F; Cardon S; Chaianantakul N; Pallerla M; Burlina F; Frontera A; Sagan S
    Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183098. PubMed ID: 31676372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells.
    Hirose H; Takeuchi T; Osakada H; Pujals S; Katayama S; Nakase I; Kobayashi S; Haraguchi T; Futaki S
    Mol Ther; 2012 May; 20(5):984-93. PubMed ID: 22334015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated repeat problems: Combinatorial effect of C9orf72-derived dipeptide repeat proteins.
    Darling AL; Breydo L; Rivas EG; Gebru NT; Zheng D; Baker JD; Blair LJ; Dickey CA; Koren J; Uversky VN
    Int J Biol Macromol; 2019 Apr; 127():136-145. PubMed ID: 30639592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arginine-rich cell-penetrating peptide-modified extracellular vesicles for active macropinocytosis induction and efficient intracellular delivery.
    Nakase I; Noguchi K; Aoki A; Takatani-Nakase T; Fujii I; Futaki S
    Sci Rep; 2017 May; 7(1):1991. PubMed ID: 28512335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The uptake of arginine-rich cell-penetrating peptides: putting the puzzle together.
    Brock R
    Bioconjug Chem; 2014 May; 25(5):863-8. PubMed ID: 24679171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Advances in the research and application of cell penetrating peptides].
    Xie Y; Wang S; Yuan Q; Xie N
    Sheng Wu Gong Cheng Xue Bao; 2019 Jul; 35(7):1162-1173. PubMed ID: 31328473
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Shiota T; Nagata R; Kikuchi S; Nanaura H; Matsubayashi M; Nakanishi M; Kobashigawa S; Isozumi N; Kiriyama T; Nagayama K; Sugie K; Yamashiro Y; Mori E
    Front Cell Dev Biol; 2022; 10():750829. PubMed ID: 35399536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death.
    Wen X; Tan W; Westergard T; Krishnamurthy K; Markandaiah SS; Shi Y; Lin S; Shneider NA; Monaghan J; Pandey UB; Pasinelli P; Ichida JK; Trotti D
    Neuron; 2014 Dec; 84(6):1213-25. PubMed ID: 25521377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Neurons and Differentiated NSC-34 Cells Are More Susceptible to Arginine-Rich ALS Dipeptide Repeat Protein-Associated Toxicity than Non-Differentiated NSC-34 and CHO Cells.
    Gill AL; Wang MZ; Levine B; Premasiri A; Vieira FG
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loosening of Lipid Packing Promotes Oligoarginine Entry into Cells.
    Murayama T; Masuda T; Afonin S; Kawano K; Takatani-Nakase T; Ida H; Takahashi Y; Fukuma T; Ulrich AS; Futaki S
    Angew Chem Int Ed Engl; 2017 Jun; 56(26):7644-7647. PubMed ID: 28597524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane permeation of arginine-rich cell-penetrating peptides independent of transmembrane potential as a function of lipid composition and membrane fluidity.
    Wallbrecher R; Ackels T; Olea RA; Klein MJ; Caillon L; Schiller J; Bovée-Geurts PH; van Kuppevelt TH; Ulrich AS; Spehr M; Adjobo-Hermans MJW; Brock R
    J Control Release; 2017 Jun; 256():68-78. PubMed ID: 28411183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Versatility of cell-penetrating peptides for intracellular delivery of siRNA.
    Singh T; Murthy ASN; Yang HJ; Im J
    Drug Deliv; 2018 Nov; 25(1):1996-2006. PubMed ID: 30799658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
    Walrant A; Cardon S; Burlina F; Sagan S
    Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Widespread displacement of DNA- and RNA-binding factors underlies toxicity of arginine-rich cell-penetrating peptides.
    Lafarga V; Sirozh O; Díaz-López I; Galarreta A; Hisaoka M; Zarzuela E; Boskovic J; Jovanovic B; Fernandez-Leiro R; Muñoz J; Stoecklin G; Ventoso I; Fernandez-Capetillo O
    EMBO J; 2021 Jul; 40(13):e103311. PubMed ID: 33978236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomics and
    Hartmann H; Hornburg D; Czuppa M; Bader J; Michaelsen M; Farny D; Arzberger T; Mann M; Meissner F; Edbauer D
    Life Sci Alliance; 2018 May; 1(2):e201800070. PubMed ID: 30456350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties.
    Meloni BP; Milani D; Edwards AB; Anderton RS; O'Hare Doig RL; Fitzgerald M; Palmer TN; Knuckey NW
    Pharmacol Ther; 2015 Sep; 153():36-54. PubMed ID: 26048328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COPA and SLC4A4 are required for cellular entry of arginine-rich peptides.
    Tsumuraya T; Matsushita M
    PLoS One; 2014; 9(1):e86639. PubMed ID: 24489756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.